TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2833607
log Bayes Factor = <0.0001
Chromosome 21   position 33,381,040  (GRCh37) Explore rs2833607 on Ensembl!
Variant rs2833607 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K56.5 Intestinal adhesions [bands] with obstruction
0.000 0.931 0.069
K56.7 Ileus, unspecified
0.000 0.952 0.048
K56 Paralytic ileus and intestinal obstruction without hernia
0.000 0.953 0.047
K56.6 Other and unspecified intestinal obstruction
0.000 0.966 0.034
K56.1 Intussusception
0.000 0.966 0.034
K56.3 Gallstone ileus
0.000 0.971 0.029
K56.2 Volvulus
0.000 0.972 0.028
M47.80 Other spondylosis (Multiple sites in spine)
0.000 0.974 0.026
K56.4 Other impaction of intestine
0.000 0.975 0.025
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.024 0.976 0.000
K56.0 Paralytic ileus
0.000 0.977 0.023
M05.9 Seropositive rheumatoid arthritis, unspecified
0.022 0.978 0.000
M47.8 Other spondylosis
0.000 0.980 0.020
M47 Spondylosis
0.000 0.981 0.019
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)
0.019 0.981 0.000
M47.2 Other spondylosis with radiculopathy
0.000 0.981 0.019
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.019 0.981 0.000
M47.9 Spondylosis, unspecified
0.000 0.982 0.018
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)
0.018 0.982 0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.018 0.982 0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)
0.000 0.983 0.017
M47.96 Spondylosis, unspecified (Lumbar region)
0.000 0.983 0.017
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)
0.017 0.983 0.000
M47.89 Other spondylosis (Site unspecified)
0.000 0.983 0.017
M47.22 Other spondylosis with radiculopathy (Cervical region)
0.000 0.983 0.017
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)
0.016 0.984 0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.016 0.984 0.000
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)
0.016 0.984 0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)
0.016 0.984 0.000
M47.1 Other spondylosis with myelopathy
0.000 0.984 0.016
M47.97 Spondylosis, unspecified (Lumbosacral region)
0.000 0.985 0.015
M47.88 Other spondylosis (Sacral and sacrococcygeal region)
0.000 0.985 0.015
M47.12 Other spondylosis with myelopathy (Cervical region)
0.000 0.985 0.015
M47.85 Other spondylosis (Thoracolumbar region)
0.000 0.985 0.014
M47.99 Spondylosis, unspecified (Site unspecified)
0.000 0.985 0.015
M47.83 Other spondylosis (Cervicothoracic region)
0.000 0.986 0.014
M47.81 Other spondylosis (Occipito-atlanto-axial region)
0.000 0.986 0.014
M47.0 Anterior spinal and vertebral artery compression syndromes
0.000 0.986 0.014
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)
0.000 0.986 0.014
U80.1 Methicillin resistant agent
0.000 0.986 0.014
M47.29 Other spondylosis with radiculopathy (Site unspecified)
0.000 0.986 0.014
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)
0.000 0.986 0.014
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)
0.000 0.986 0.014
M47.24 Other spondylosis with radiculopathy (Thoracic region)
0.000 0.986 0.014
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)
0.000 0.986 0.014
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)
0.000 0.986 0.014
M47.92 Spondylosis, unspecified (Cervical region)
0.000 0.986 0.014
M47.84 Other spondylosis (Thoracic region)
0.000 0.986 0.013
M47.94 Spondylosis, unspecified (Thoracic region)
0.000 0.987 0.013
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)
0.000 0.987 0.013
M47.93 Spondylosis, unspecified (Cervicothoracic region)
0.000 0.987 0.013
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)
0.000 0.987 0.013
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.987 0.013
M41.96 Scoliosis, unspecified (Lumbar region)
0.000 0.987 0.013
U80 Agent resistant to penicillin and related antibiotics
0.000 0.987 0.013
M47.95 Spondylosis, unspecified (Thoracolumbar region)
0.000 0.987 0.012
M41.9 Scoliosis, unspecified
0.000 0.987 0.012
U80.0 Penicillin resistant agent
0.000 0.988 0.012
M47.19 Other spondylosis with myelopathy (Site unspecified)
0.000 0.988 0.012
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)
0.000 0.988 0.012
M47.17 Other spondylosis with myelopathy (Lumbosacral region)
0.000 0.988 0.012
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)
0.000 0.988 0.012
M47.14 Other spondylosis with myelopathy (Thoracic region)
0.000 0.988 0.012
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)
0.000 0.988 0.012
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)
0.000 0.988 0.012
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)
0.000 0.988 0.012
M41.95 Scoliosis, unspecified (Thoracolumbar region)
0.000 0.989 0.011
M47.90 Spondylosis, unspecified (Multiple sites in spine)
0.000 0.989 0.011
M41.99 Scoliosis, unspecified (Site unspecified)
0.000 0.989 0.011
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)
0.000 0.990 0.010
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)
0.000 0.990 0.010
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)
0.000 0.990 0.010
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)
0.000 0.990 0.010
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)
0.000 0.990 0.010
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)
0.000 0.990 0.010
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)
0.000 0.990 0.010
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)
0.000 0.990 0.010
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)
0.000 0.990 0.010
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)
0.000 0.990 0.010
M41.94 Scoliosis, unspecified (Thoracic region)
0.000 0.990 0.010
M05 Seropositive rheumatoid arthritis
0.010 0.990 0.000
U80.8 Agent resistant to other penicillin-related antibiotic
0.000 0.990 0.010
M47.16 Other spondylosis with myelopathy (Lumbar region)
0.000 0.990 0.009
M47.87 Other spondylosis (Lumbosacral region)
0.000 0.991 0.009
M47.86 Other spondylosis (Lumbar region)
0.000 0.991 0.009
M41.98 Scoliosis, unspecified (Sacral and sacrococcygeal region)
0.000 0.991 0.009
M41.93 Scoliosis, unspecified (Cervicothoracic region)
0.000 0.991 0.009
M41.92 Scoliosis, unspecified (Cervical region)
0.000 0.991 0.009
M41.91 Scoliosis, unspecified (Occipito-atlanto-axial region)
0.000 0.991 0.009
M41.97 Scoliosis, unspecified (Lumbosacral region)
0.000 0.991 0.009
M41.90 Scoliosis, unspecified (Multiple sites in spine)
0.000 0.991 0.009
Z04.9 Examination and observation for unspecified reason
0.009 0.991 0.000
M47.82 Other spondylosis (Cervical region)
0.000 0.992 0.008
Y52 Agents primarily affecting the cardiovascular system
0.008 0.992 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.008 0.992 0.000
Z04.3 Examination and observation following other accident
0.008 0.992 0.000
M41 Scoliosis
0.000 0.992 0.007
M05.8 Other seropositive rheumatoid arthritis
0.007 0.993 0.000
M05.3 Rheumatoid arthritis with involvement of other organs and systems
0.007 0.993 0.000
M05.2 Rheumatoid vasculitis
0.007 0.993 0.000
M05.1 Rheumatoid lung disease
0.007 0.993 0.000
M05.0 Felty's syndrome
0.007 0.993 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.007 0.993 0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.000 0.993 0.007
Z95.8 Presence of other cardiac and vascular implants and grafts
0.007 0.993 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.007 0.993 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.007 0.993 0.000
Y52.7 Peripheral vasodilators
0.007 0.993 0.000
Y45.1 Salicylates
0.006 0.994 0.000
U51 Admission status on psychiatric patients
0.000 0.994 0.006
U51.0 Not Previously admitted to a psyciatric hospital
0.000 0.994 0.006
M41.8 Other forms of scoliosis
0.000 0.994 0.006
Y52.1 Calcium-channel blockers
0.006 0.994 0.000
Z04 Examination and observation for other reasons
0.006 0.994 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.006 0.994 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.006 0.994 0.000
C54.1 Endometrium
0.006 0.994 0.000
M54.22 Cervicalgia (Cervical region)
0.000 0.994 0.006
M41.4 Neuromuscular scoliosis
0.000 0.994 0.006
M41.3 Thoracogenic scoliosis
0.000 0.994 0.006
M41.2 Other idiopathic scoliosis
0.000 0.994 0.006
M41.1 Juvenile idiopathic scoliosis
0.000 0.994 0.006
M41.0 Infantile idiopathic scoliosis
0.000 0.994 0.006
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.006 0.994 0.000
M41.5 Other secondary scoliosis
0.000 0.994 0.005
M05.09 Felty's syndrome (Site unspecified)
0.005 0.994 0.000
M05.08 Felty's syndrome (Other)
0.005 0.994 0.000
M05.07 Felty's syndrome (Ankle and foot)
0.005 0.994 0.000
M05.06 Felty's syndrome (Lower leg)
0.005 0.994 0.000
M05.05 Felty's syndrome (Pelvic region and thigh)
0.005 0.994 0.000
M05.04 Felty's syndrome (Hand)
0.005 0.994 0.000
M05.03 Felty's syndrome (Forearm)
0.005 0.994 0.000
M05.02 Felty's syndrome (Upper arm)
0.005 0.994 0.000
M05.01 Felty's syndrome (Shoulder region)
0.005 0.994 0.000
M05.00 Felty's syndrome (Multiple sites)
0.005 0.994 0.000
M05.19 Rheumatoid lung disease (Site unspecified)
0.005 0.994 0.000
M05.18 Rheumatoid lung disease (Other)
0.005 0.994 0.000
M05.17 Rheumatoid lung disease (Ankle and foot)
0.005 0.994 0.000
M05.16 Rheumatoid lung disease (Lower leg)
0.005 0.994 0.000
M05.15 Rheumatoid lung disease (Pelvic region and thigh)
0.005 0.994 0.000
M05.14 Rheumatoid lung disease (Hand)
0.005 0.994 0.000
M05.13 Rheumatoid lung disease (Forearm)
0.005 0.994 0.000
M05.12 Rheumatoid lung disease (Upper arm)
0.005 0.994 0.000
M05.11 Rheumatoid lung disease (Shoulder region)
0.005 0.994 0.000
M05.10 Rheumatoid lung disease (Multiple sites)
0.005 0.994 0.000
M05.29 Rheumatoid vasculitis (Site unspecified)
0.005 0.994 0.000
M05.28 Rheumatoid vasculitis (Other)
0.005 0.994 0.000
M05.27 Rheumatoid vasculitis (Ankle and foot)
0.005 0.994 0.000
M05.26 Rheumatoid vasculitis (Lower leg)
0.005 0.994 0.000
M05.25 Rheumatoid vasculitis (Pelvic region and thigh)
0.005 0.994 0.000
M05.24 Rheumatoid vasculitis (Hand)
0.005 0.994 0.000
M05.23 Rheumatoid vasculitis (Forearm)
0.005 0.994 0.000
M05.22 Rheumatoid vasculitis (Upper arm)
0.005 0.994 0.000
M05.21 Rheumatoid vasculitis (Shoulder region)
0.005 0.994 0.000
M05.20 Rheumatoid vasculitis (Multiple sites)
0.005 0.994 0.000
M05.39 Rheumatoid arthritis with involvement of other organs and systems (Site unspecified)
0.005 0.994 0.000
M05.38 Rheumatoid arthritis with involvement of other organs and systems (Other)
0.005 0.994 0.000
M05.37 Rheumatoid arthritis with involvement of other organs and systems (Ankle and foot)
0.005 0.994 0.000
M05.36 Rheumatoid arthritis with involvement of other organs and systems (Lower leg)
0.005 0.994 0.000
M05.35 Rheumatoid arthritis with involvement of other organs and systems (Pelvic region and thigh)
0.005 0.994 0.000
M05.34 Rheumatoid arthritis with involvement of other organs and systems (Hand)
0.005 0.994 0.000
M05.33 Rheumatoid arthritis with involvement of other organs and systems (Forearm)
0.005 0.994 0.000
M05.32 Rheumatoid arthritis with involvement of other organs and systems (Upper arm)
0.005 0.994 0.000
M05.31 Rheumatoid arthritis with involvement of other organs and systems (Shoulder region)
0.005 0.994 0.000
M05.30 Rheumatoid arthritis with involvement of other organs and systems (Multiple sites)
0.005 0.994 0.000
M05.89 Other seropositive rheumatoid arthritis (Site unspecified)
0.005 0.994 0.000
M05.88 Other seropositive rheumatoid arthritis (Other)
0.005 0.994 0.000
M05.87 Other seropositive rheumatoid arthritis (Ankle and foot)
0.005 0.994 0.000
M05.86 Other seropositive rheumatoid arthritis (Lower leg)
0.005 0.994 0.000
M05.85 Other seropositive rheumatoid arthritis (Pelvic region and thigh)
0.005 0.994 0.000
M05.84 Other seropositive rheumatoid arthritis (Hand)
0.005 0.994 0.000
M05.83 Other seropositive rheumatoid arthritis (Forearm)
0.005 0.994 0.000
M05.82 Other seropositive rheumatoid arthritis (Upper arm)
0.005 0.994 0.000
M05.81 Other seropositive rheumatoid arthritis (Shoulder region)
0.005 0.994 0.000
M05.80 Other seropositive rheumatoid arthritis (Multiple sites)
0.005 0.994 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.006 0.994 0.000
H74.4 Polyp of middle ear
0.006 0.994 0.000
Y40 Systemic antibiotics
0.005 0.995 0.000
U50 Level of care administered to neonates
0.000 0.995 0.005
U07 Emergency use of U07
0.000 0.995 0.005
U06 Emergency use of U06
0.000 0.995 0.005
U04 Severe acute respiratory syndrome [SARS]
0.000 0.995 0.005
U52 First in a series of a regular day/night admissions
0.000 0.995 0.005
Y51 Drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.005 0.995 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.005 0.995 0.000
M41.86 Other forms of scoliosis (Lumbar region)
0.000 0.995 0.005
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.005 0.995 0.000
Y40.3 Macrolides
0.005 0.995 0.000
U51.2 Previously admitted to a psychiatric hospital of another provider
0.000 0.995 0.005
Y53 Agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
Y45.5 4-Aminophenol derivatives
0.005 0.995 0.000
Z04.6 General psychiatric examination, requested by authority
0.005 0.995 0.000
Y40.5 Aminoglycosides
0.005 0.995 0.000
Y55.4 Expectorants
0.005 0.995 0.000
M41.89 Other forms of scoliosis (Site unspecified)
0.000 0.995 0.004
M41.88 Other forms of scoliosis (Sacral and sacrococcygeal region)
0.000 0.995 0.004
M41.87 Other forms of scoliosis (Lumbosacral region)
0.000 0.995 0.004
M41.85 Other forms of scoliosis (Thoracolumbar region)
0.000 0.995 0.004
M41.84 Other forms of scoliosis (Thoracic region)
0.000 0.995 0.004
M41.83 Other forms of scoliosis (Cervicothoracic region)
0.000 0.995 0.004
M41.82 Other forms of scoliosis (Cervical region)
0.000 0.995 0.004
M41.81 Other forms of scoliosis (Occipito-atlanto-axial region)
0.000 0.995 0.004
M41.80 Other forms of scoliosis (Multiple sites in spine)
0.000 0.995 0.004
Y40.6 Rifamycins
0.005 0.995 0.000
S49.9 Unspecified injury of shoulder and upper arm
0.000 0.995 0.005
U81 Agent resistant to vancomycin and related antibiotics
0.000 0.995 0.004
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.995 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.004 0.995 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.004 0.995 0.000
Y40.9 Systemic antibiotic, unspecified
0.004 0.995 0.000
Y40.4 Tetracyclines
0.004 0.995 0.000
Z04.4 Examination and observation following alleged rape and seduction
0.004 0.995 0.000
Z04.0 Blood-alcohol and blood-drug test
0.004 0.995 0.000
Z04.2 Examination and observation following work accident
0.004 0.995 0.000
Y42.4 Oral contraceptives
0.004 0.996 0.000
Y59 Other and unspecified vaccines and biological substances
0.004 0.996 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.004 0.996 0.000
M41.09 Infantile idiopathic scoliosis (Site unspecified)
0.000 0.996 0.004
M41.08 Infantile idiopathic scoliosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.07 Infantile idiopathic scoliosis (Lumbosacral region)
0.000 0.996 0.004
M41.06 Infantile idiopathic scoliosis (Lumbar region)
0.000 0.996 0.004
M41.05 Infantile idiopathic scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.04 Infantile idiopathic scoliosis (Thoracic region)
0.000 0.996 0.004
M41.03 Infantile idiopathic scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.02 Infantile idiopathic scoliosis (Cervical region)
0.000 0.996 0.004
M41.01 Infantile idiopathic scoliosis (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.00 Infantile idiopathic scoliosis (Multiple sites in spine)
0.000 0.996 0.004
M41.19 Juvenile idiopathic scoliosis (Site unspecified)
0.000 0.996 0.004
M41.18 Juvenile idiopathic scoliosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.17 Juvenile idiopathic scoliosis (Lumbosacral region)
0.000 0.996 0.004
M41.16 Juvenile idiopathic scoliosis (Lumbar region)
0.000 0.996 0.004
M41.15 Juvenile idiopathic scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.14 Juvenile idiopathic scoliosis (Thoracic region)
0.000 0.996 0.004
M41.13 Juvenile idiopathic scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.12 Juvenile idiopathic scoliosis (Cervical region)
0.000 0.996 0.004
M41.11 Juvenile idiopathic scoliosis (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.10 Juvenile idiopathic scoliosis (Multiple sites in spine)
0.000 0.996 0.004
M41.29 Other idiopathic scoliosis (Site unspecified)
0.000 0.996 0.004
M41.28 Other idiopathic scoliosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.27 Other idiopathic scoliosis (Lumbosacral region)
0.000 0.996 0.004
M41.26 Other idiopathic scoliosis (Lumbar region)
0.000 0.996 0.004
M41.25 Other idiopathic scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.24 Other idiopathic scoliosis (Thoracic region)
0.000 0.996 0.004
M41.23 Other idiopathic scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.22 Other idiopathic scoliosis (Cervical region)
0.000 0.996 0.004
M41.21 Other idiopathic scoliosis (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.20 Other idiopathic scoliosis (Multiple sites in spine)
0.000 0.996 0.004
M41.39 Thoracogenic scoliosis-Site unspe
0.000 0.996 0.004
M41.38 Thoracogenic scoliosis-Sacral/sacrococ
0.000 0.996 0.004
M41.37 Thoracogenic scoliosis-Lumbosacral
0.000 0.996 0.004
M41.36 Thoracogenic scoliosis-Lumbar
0.000 0.996 0.004
M41.35 Thoracogenic scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.34 Thoracogenic scoliosis (Thoracic region)
0.000 0.996 0.004
M41.33 Thoracogenic scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.32 Thoracogenic scoliosis-Cervical
0.000 0.996 0.004
M41.31 Thoracogenic scoliosis-Occipit-atl-axl
0.000 0.996 0.004
M41.30 Thoracogenic scoliosis (Multiple sites in spine)
0.000 0.996 0.004
M41.49 Neuromuscular scoliosis (Site unspecified)
0.000 0.996 0.004
M41.48 Neuromuscular scoliosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.47 Neuromuscular scoliosis (Lumbosacral region)
0.000 0.996 0.004
M41.46 Neuromuscular scoliosis (Lumbar region)
0.000 0.996 0.004
M41.45 Neuromuscular scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.44 Neuromuscular scoliosis (Thoracic region)
0.000 0.996 0.004
M41.43 Neuromuscular scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.42 Neuromuscular scoliosis (Cervical region)
0.000 0.996 0.004
M41.41 Neuromuscular scoliosis (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.40 Neuromuscular scoliosis (Multiple sites in spine)
0.000 0.996 0.004
Y52.4 Angiotensin-converting-enzyme inhibitors
0.004 0.996 0.000
Y58 Bacterial vaccines
0.004 0.996 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.004 0.996 0.000
M41.59 Other secondary scoliosis (Site unspecified)
0.000 0.996 0.004
M41.58 Other secondary scoliosis (Sacral and sacrococcygeal region)
0.000 0.996 0.004
M41.57 Other secondary scoliosis (Lumbosacral region)
0.000 0.996 0.004
M41.55 Other secondary scoliosis (Thoracolumbar region)
0.000 0.996 0.004
M41.54 Other secondary scoliosis (Thoracic region)
0.000 0.996 0.004
M41.53 Other secondary scoliosis (Cervicothoracic region)
0.000 0.996 0.004
M41.52 Other secondary scoliosis (Cervical region)
0.000 0.996 0.004
M41.51 Other secondary scoliosis (Occipito-atlanto-axial region)
0.000 0.996 0.004
M41.50 Other secondary scoliosis (Multiple sites in spine)
0.000 0.996 0.004
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.996 0.000
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified
0.004 0.996 0.000
Y45.4 Antirheumatics
0.004 0.996 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.004 0.996 0.000
Y42.1 Thyroid hormones and substitutes
0.004 0.996 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.004 0.996 0.000
M41.56 Other secondary scoliosis (Lumbar region)
0.000 0.996 0.004
Y45.8 Other analgesics and antipyretics
0.004 0.996 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.004 0.996 0.000
Y40.7 Antifungal antibiotics, systemically used
0.004 0.996 0.000
Y40.2 Chloramphenicol group
0.004 0.996 0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified
0.000 0.996 0.004
U06.9 Emergency use of U06.9
0.000 0.996 0.004
U06.8 Emergency use of U06.8
0.000 0.996 0.004
U06.7 Emergency use of U06.7
0.000 0.996 0.004
U06.6 Emergency use of U06.6
0.000 0.996 0.004
U06.5 Emergency use of U06.5
0.000 0.996 0.004
U06.4 Emergency use of U06.4
0.000 0.996 0.004
U06.3 Emergency use of U06.3
0.000 0.996 0.004
U06.2 Emergency use of U06.2
0.000 0.996 0.004
U06.1 Emergency use of U06.1
0.000 0.996 0.004
U06.0 Emergency use of U06.0
0.000 0.996 0.004
U07.9 Emergency use of U07.9
0.000 0.996 0.004
U07.8 Emergency use of U07.8
0.000 0.996 0.004
U07.7 Emergency use of U07.7
0.000 0.996 0.004
U07.6 Emergency use of U07.6
0.000 0.996 0.004
U07.5 Emergency use of U07.5
0.000 0.996 0.004
U07.4 Emergency use of U07.4
0.000 0.996 0.004
U07.3 Emergency use of U07.3
0.000 0.996 0.004
U07.2 Emergency use of U07.2
0.000 0.996 0.004
U07.1 Emergency use of U07.1
0.000 0.996 0.004
U07.0 Emergency use of U07.0
0.000 0.996 0.004
U50.9 Inquest Adjourned Death
0.000 0.996 0.004
U50.3 Level of care administered to neonates (Maximal Intensive Care)
0.000 0.996 0.004
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)
0.000 0.996 0.004
U50.1 Level of care administered to neonates (Special Care)
0.000 0.996 0.004
U50.0 Level of care administered to neonates (Normal Care)
0.000 0.996 0.004
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.004 0.996 0.000
Y40.0 Penicillins
0.004 0.996 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.004 0.996 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.004 0.996 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.004 0.996 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.004 0.996 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.004 0.996 0.000
Y51.0 Anticholinesterase agents
0.004 0.996 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.004 0.996 0.000
Y48 Anaesthetics and therapeutic gases
0.004 0.996 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.004 0.996 0.000
S70.9 Superficial injury of hip and thigh, unspecified
0.004 0.996 0.000
Y45.2 Propionic acid derivatives
0.004 0.996 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.004 0.996 0.000
Y42.9 Other and unspecified hormone antagonists
0.004 0.996 0.000
Y42.2 Antithyroid drugs
0.004 0.996 0.000
Y53.4 Other laxatives
0.004 0.996 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.004 0.996 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.004 0.996 0.000
Y55.5 Anticommon cold drugs
0.004 0.996 0.000
Y55.3 Antitussives
0.004 0.996 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.004 0.996 0.000
Y55.0 Oxytocic drugs
0.004 0.996 0.000
Z04.5 Examination and observation following other inflicted injury
0.004 0.996 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.004 0.996 0.000
M54.29 Cervicalgia-Site unspe
0.000 0.996 0.004
M54.2 Cervicalgia
0.000 0.996 0.004
Y42.0 Glucocorticoids and synthetic analogs
0.004 0.996 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.004 0.996 0.000
H74 Other disorders of middle ear and mastoid
0.004 0.996 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.004 0.996 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.004 0.996 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.004 0.996 0.000
Y53.7 Emetics
0.004 0.996 0.000
Y53.6 Antidiarrhoeal drugs
0.004 0.996 0.000
Y53.5 Digestants
0.004 0.996 0.000
Y53.3 Saline and osmotic laxatives
0.004 0.996 0.000
Y53.2 Stimulant laxatives
0.004 0.996 0.000
Y53.0 Histamine H2-receptor antagonists
0.004 0.996 0.000
U51.1 Previously admitted to a psychiatric hospital of the provider
0.000 0.996 0.003
Y42.7 Androgens and anabolic congeners
0.004 0.996 0.000
U81.8 Agent resistant to other vancomycin-related antibiotic
0.000 0.996 0.003
M50.3 Other cervical disk degeneration
0.000 0.996 0.004
Y48.4 Anaesthetic, unspecified
0.003 0.996 0.000
Y46.2 Hydantoin derivatives
0.003 0.996 0.000
B37.9 Candidiasis, unspecified
0.003 0.997 0.000
H74.2 Discontinuity and dislocation of ear ossicles
0.003 0.997 0.000
Y59.3 Immunoglobulin
0.003 0.997 0.000
Y46.7 Anti-Parkinsonism drugs
0.003 0.997 0.000
Y59.9 Vaccine or biological substance, unspecified
0.003 0.997 0.000
Y59.8 Other specified vaccines and biological substances
0.003 0.997 0.000
Y59.2 Protozoal vaccines
0.003 0.997 0.000
Y59.1 Rickettsial vaccines
0.003 0.997 0.000
Y59.0 Viral vaccines
0.003 0.997 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.003 0.997 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.003 0.997 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.003 0.997 0.000
Y47.4 Bromine compounds
0.003 0.997 0.000
Y47.3 Paraldehyde
0.003 0.997 0.000
Y47.2 Chloral derivatives
0.003 0.997 0.000
Y47.1 Benzodiazepines
0.003 0.997 0.000
Y47.0 Barbiturates, not elsewhere classified
0.003 0.997 0.000
Y50.9 Central nervous system stimulant, unspecified
0.003 0.997 0.000
Y50.8 Other central nervous system stimulants
0.003 0.997 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.003 0.997 0.000
Y50.1 Opioid receptor antagonists
0.003 0.997 0.000
Y50.0 Analeptics
0.003 0.997 0.000
Y58.9 Other and unspecified bacterial vaccines
0.003 0.997 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.003 0.997 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.003 0.997 0.000
Y58.5 Diphtheria vaccine
0.003 0.997 0.000
Y58.4 Tetanus vaccine
0.003 0.997 0.000
Y58.3 Plague vaccine
0.003 0.997 0.000
Y58.2 Cholera vaccine
0.003 0.997 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.003 0.997 0.000
Y58.0 BCG vaccine
0.003 0.997 0.000
Y44 Agents primarily affecting blood constituents
0.003 0.997 0.000
M54.59 Low back pain (Site unspecified)
0.000 0.997 0.003
Y57 Other and unspecified drugs and medicaments
0.003 0.997 0.000
Y46.8 Antispasticity drugs
0.003 0.997 0.000
Y46.5 Valproic acid
0.003 0.997 0.000
Y46.3 Deoxybarbiturates
0.003 0.997 0.000
Y46.1 Oxazolidinediones
0.003 0.997 0.000
Y46.0 Succinimides
0.003 0.997 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.003 0.997 0.000
Z04.1 Examination and observation following transport accident
0.003 0.997 0.000
S60.9 Superficial injury of wrist and hand, unspecified
0.003 0.997 0.000
Y46.6 Other and unspecified antiepileptics
0.003 0.997 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.003 0.997 0.000
Y48.5 Therapeutic gases
0.003 0.997 0.000
Y48.1 Parenteral anaesthetics
0.003 0.997 0.000
Y48.0 Inhaled anaesthetics
0.003 0.997 0.000
Y54.7 Agents affecting calcification
0.003 0.997 0.000
Y56.9 Topical agent, unspecified
0.003 0.997 0.000
Y56.8 Other topical agents
0.003 0.997 0.000
Y56.7 Dental drugs, topically applied
0.003 0.997 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.003 0.997 0.000
Y56.5 Ophthalmological drugs and preparations
0.003 0.997 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.003 0.997 0.000
Y56.3 Emollients, demulcents and protectants
0.003 0.997 0.000
Y56.2 Local astringents and local detergents
0.003 0.997 0.000
Y56.1 Antipruritics
0.003 0.997 0.000
Z96.8 Presence of other specified functional implants
0.000 0.997 0.003
C54 Malignant neoplasm of corpus uteri
0.003 0.997 0.000
H74.1 Adhesive middle ear disease
0.003 0.997 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.003 0.997 0.000
H74.9 Disorder of middle ear and mastoid, unspecified
0.003 0.997 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.003 0.997 0.000
M54.28 Cervicalgia-Sacral/sacrococ
0.000 0.997 0.003
M54.27 Cervicalgia-Lumbosacral
0.000 0.997 0.003
M54.26 Cervicalgia-Lumbar
0.000 0.997 0.003
M54.25 Cervicalgia-Thoracolumbar
0.000 0.997 0.003
M54.24 Cervicalgia-Thoracic
0.000 0.997 0.003
M54.21 Cervicalgia (Occipito-atlanto-axial region)
0.000 0.997 0.003
M54.20 Cervicalgia-Mult site
0.000 0.997 0.003
Y54.9 Mineral salts, not elsewhere classified
0.003 0.997 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.003 0.997 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.003 0.997 0.000
Y54.0 Mineralocorticoids
0.003 0.997 0.000
Y42.5 Other oestrogens and progestogens
0.003 0.997 0.000
Y57.5 X-ray contrast media
0.003 0.997 0.000
Y54.8 Agents affecting uric acid metabolism
0.003 0.997 0.000
I49.3 Ventricular premature depolarisation
0.000 0.997 0.003
Y40.8 Other systemic antibiotics
0.003 0.997 0.000
Y48.2 Other and unspecified general anaesthetics
0.003 0.997 0.000
M40-M43 Deforming dorsopathies
0.000 0.997 0.003
Y41.1 Antimycobacterial drugs
0.003 0.997 0.000
A04.8 Other specified bacterial intestinal infections
0.000 0.997 0.003
Y54.5 Other diuretics
0.003 0.997 0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.000 0.997 0.003
G55.2 Nerve root and plexus compressions in spondylosis
0.000 0.997 0.003
U81.0 Vancomycin resistant agent
0.000 0.997 0.002
Y54.4 Loop [high-ceiling] diuretics
0.003 0.997 0.000
Y46.4 Iminostilbenes
0.003 0.997 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.003 0.997 0.000
N28.9 Disorder of kidney and ureter, unspecified
0.000 0.997 0.003
M54.23 Cervicalgia (Cervicothoracic region)
0.000 0.997 0.003
N99.4 Postprocedural pelvic peritoneal adhesions
0.000 0.997 0.003
Y48.3 Local anaesthetics
0.003 0.997 0.000
C54.9 Corpus uteri, unspecified
0.003 0.997 0.000
G61.0 Guillain-Barre syndrome
0.003 0.997 0.000
Y44.5 Thrombolytic drugs
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.003 0.997 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.997 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.002 0.997 0.000
Y44.7 Plasma substitutes
0.002 0.997 0.000
Y44.6 Natural blood and blood products
0.002 0.997 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.002 0.997 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.002 0.997 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.003 0.997 0.000
Y57.7 Vitamins, not elsewhere classified
0.002 0.997 0.000
Y57.4 Pharmaceutical excipients
0.002 0.997 0.000
Y57.3 Alcohol deterrents
0.002 0.997 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.002 0.997 0.000
Y57.1 Lipotropic drugs
0.002 0.997 0.000
Y57.0 Appetite depressants [anorectics]
0.002 0.997 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.002 0.997 0.000
M79.69 Pain in limb (Site unspecified)
0.000 0.997 0.003
I08.3 Combined disorders of mitral, aortic and tricuspid valves
0.000 0.997 0.003
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.002 0.997 0.000
Y41.4 Anthelminthics
0.002 0.997 0.000
Y41.3 Other antiprotozoal drugs
0.002 0.997 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.002 0.997 0.000
Z04.8 Examination and observation for other specified reasons
0.003 0.997 0.000
H74.0 Tympanosclerosis
0.002 0.997 0.000
N73.9 Female pelvic inflammatory disease, unspecified
0.000 0.997 0.003
N13.9 Obstructive and reflux uropathy, unspecified
0.000 0.997 0.003
R02 Gangrene, not elsewhere classified
0.003 0.997 0.000
M43.06 Spondylolysis (Lumbar region)
0.000 0.997 0.002
C54.8 Overlapping lesion of corpus uteri
0.002 0.997 0.000
C54.3 Fundus uteri
0.002 0.997 0.000
C54.2 Myometrium
0.002 0.997 0.000
C54.0 Isthmus uteri
0.002 0.997 0.000
W20.8 Other specified place
0.002 0.997 0.000
Y49.9 Psychotropic drug, unspecified
0.002 0.997 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.002 0.997 0.000
Y49.7 Psychostimulants with abuse potential
0.002 0.997 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.002 0.997 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.002 0.997 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.002 0.997 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.002 0.997 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.